ArticleCancer management and research2021

Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China.

Yamin Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.